{
    "clinical_study": {
        "@rank": "112821", 
        "arm_group": [
            {
                "arm_group_label": "Ropivacaine", 
                "arm_group_type": "Experimental", 
                "description": "caudal block with 1 ml/kg of ropivacaine 0.2%"
            }, 
            {
                "arm_group_label": "saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "caudal block with 1 ml/kg of saline"
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of the present study was to investigate the role of pro-inflammatory cytokines in\n      myocardial dysfunction and injury resulting from noncardiac injury in children and whether\n      or not anti-inflammatory treatment with caudal block prevents pro-inflammatory\n      cytokines-associated myocardial dysfunction and injury following noncardiac surgery."
        }, 
        "brief_title": "Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cardiac Dysfunction", 
            "Myocardial Injury"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children diagnosed for developmental dysplasia of the hip (DDH) undergoing Salter\n             innominate osteotomy will be recruited into the study.\n\n        Exclusion Criteria:\n\n          -  Children with anemia, electrolyte disturbances, abnormal acid-base status, bleeding\n             diathesis, history of allergy to local anesthetics, neurologic and spinal diseases,\n             skin infections on the caudal area, renal dysfunction, symptomatic cardiovascular and\n             respiratory disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02144766", 
            "org_study_id": "060717"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ropivacaine", 
                "description": "caudal block with 1 ml/kg of ropivacaine 0.2%", 
                "intervention_name": "ropivacaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "saline", 
                "description": "caudal block with 1 ml/kg of saline", 
                "intervention_name": "saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "zip": "200092"
                }, 
                "name": "Xinhua Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prevention of Pro-inflammatory Cytokines-associated Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block", 
        "overall_contact": {
            "email": "chensiqin1983@hotmail.com", 
            "last_name": "SiQin Chen, MD", 
            "phone": "+8613918085974"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 3h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at 24h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 24h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at 48h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 48h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of NT(N terminal)-proBNP at 72h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 72h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 3h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at 24h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 24h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at 48h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 48h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of CK(creatine kinase)-MB at 72h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 72h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 3h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at 24h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 24h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at 48h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 48h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of cTn(troponin)I at 72h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 72h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-\u03b1 at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-\u03b1 at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 3h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-\u03b1 at 24h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 24h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-\u03b1 at 48h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 48h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of TNF(tumor necrosis factor)-\u03b1 at 72h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 72h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 3h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at 24h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 24h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at 48h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 48h after surgery"
            }, 
            {
                "measure": "change from baseline(before induction of anesthesia) in plasma concentrations of IL(interleukin)-6 at 72h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(before induction of anesthesia), 72h after surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02144766"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", 
            "investigator_full_name": "Si-Qin Chen", 
            "investigator_title": "attending doctor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "change from baseline(just before the start of surgery) in MAP(mean arterial pressure) at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(just before the start of surgery), at arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(just before the start of surgery) in MAP(mean arterial pressure) at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(just before the start of surgery), 3h after surgery"
            }, 
            {
                "measure": "change from baseline(just before the start of surgery) in CVP(central venous pressure) at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(just before the start of surgery), at arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(just before the start of surgery) in CVP(central venous pressure) at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(just before the start of surgery), 3h after surgery"
            }, 
            {
                "measure": "change from baseline(just before the start of surgery) in CO(cardiac output) at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(just before the start of surgery), at arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(just before the start of surgery) in CO(cardiac output) at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(just before the start of surgery), 3h after surgery"
            }, 
            {
                "measure": "change from baseline(just before the start of surgery) in SVR(systemic vascular resistance) at arrival in the postanesthesia care unit", 
                "safety_issue": "No", 
                "time_frame": "baseline(just before the start of surgery), at arrival in the postanesthesia care unit"
            }, 
            {
                "measure": "change from baseline(just before the start of surgery) in SVR(systemic vascular resistance) at 3h after surgery", 
                "safety_issue": "No", 
                "time_frame": "baseline(just before the start of surgery), 3h after surgery"
            }
        ], 
        "source": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Si-Qin Chen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}